LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.69 -1.47

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.67

Max

2.69

Pagrindiniai rodikliai
By Trading Economics
Pajamos	-77K -3.6M
Darbuotojai	20
EBITDA	-79K -3.6M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+178.81% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-03-23

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	24M 165M
Ankstesnė atidarymo kaina	4.16
Ankstesnė uždarymo kaina	2.69

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-13 19:08; UTC

Svarbiausios naujienos

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

2026-03-13 18:48; UTC

Uždarbis

Pagrindinės rinkos jėgos

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

2026-03-13 17:10; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

2026-03-13 17:10; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions -2-

2026-03-13 16:47; UTC

Svarbiausios naujienos

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

2026-03-13 22:27; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

2026-03-13 22:13; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

2026-03-13 22:04; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

2026-03-13 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

2026-03-13 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-13 20:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-03-13 20:02; UTC

Rinkos pokalbiai

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

2026-03-13 19:50; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

2026-03-13 19:35; UTC

Svarbiausios naujienos

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

2026-03-13 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2026-03-13 18:49; UTC

Svarbiausios naujienos

The Iran War Could Upend AI. Here's How. -- Barrons.com

2026-03-13 18:24; UTC

Svarbiausios naujienos

Impact of Middle East Conflict on TotalEnergies Activities

2026-03-13 18:00; UTC

Svarbiausios naujienos

Is War Good For the Economy? -- WSJ

2026-03-13 17:23; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

2026-03-13 16:46; UTC

Rinkos pokalbiai

Svarbiausios naujienos

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

2026-03-13 16:38; UTC

Svarbiausios naujienos

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

2026-03-13 16:34; UTC

Įsigijimai, susijungimai, perėmimai

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

2026-03-13 16:33; UTC

Įsigijimai, susijungimai, perėmimai

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

2026-03-13 16:32; UTC

Įsigijimai, susijungimai, perėmimai

EQT Completes Exit From Galderma

2026-03-13 16:20; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-03-13 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-13 16:15; UTC

Svarbiausios naujienos

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

2026-03-13 16:11; UTC

Rinkos pokalbiai

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

2026-03-13 16:00; UTC

Svarbiausios naujienos

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

2026-03-13 15:48; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

178.81% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD 178.81%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.